Neuburgh Advisers’s Elevance Health ELV Stock Holding History

Neuburgh Advisers’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$2.3M	Buy	9,570 +4,180	+78%	+$1.15M	0.07%	205
2019 Q2	$1.52M	Sell	5,390 -10,252	-66%	-$2.8M	0.05%	269
2019 Q1	$4.49M	Sell	15,642 -2,090	-12%	-$604K	0.15%	129
2018 Q4	$4.66M	Sell	17,732 -6,644	-27%	-$1.83M	0.18%	114
2018 Q3	$6.68M	Sell	24,376 -29,436	-55%	-$7.64M	0.22%	105
2018 Q2	$12.8M	Sell	53,812 -29,480	-35%	-$6.83M	0.43%	52
2018 Q1	$18.3M	Buy	83,292 +15,994	+24%	+$3.76M	0.64%	42
2017 Q4	$15.1M	Buy	67,298 +28,248	+72%	+$6.02M	0.54%	47
2017 Q3	$7.42M	Buy	39,050 +11,528	+42%	+$2.19M	0.28%	80
2017 Q2	$5.18M	Buy	27,522 +10,252	+59%	+$1.84M	0.2%	102
2017 Q1	$2.86M	Buy	17,270 +1,056	+7%	+$168K	0.11%	161
2016 Q4	$2.33M	Buy	+16,214	New	+$2.17M	0.1%	156

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return

Neuburgh Advisers's ELV Position: Q3 2019 in Review

Neuburgh Advisers increased its Elevance Health (ELV) stake by 78% in Q3 2019, buying an estimated $1.15M and bringing the position to 9,570 shares worth $2.3M. The position accounts for 0.07% of the portfolio, ranked #205.

Neuburgh Advisers first reported a position in ELV in Q4 2016 and has held it in 12 quarters since. The position peaked at $18.3M in Q1 2018. 1,014 funds tracked by Wall St. Rank hold ELV as of Q3 2019.

Neuburgh Advisers held 9,570 shares of Elevance Health worth $2.3M as of Q3 2019.
Neuburgh Advisers bought 4,180 Elevance Health shares in Q3 2019, an estimated $1.15M.
Elevance Health made up 0.07% of Neuburgh Advisers's portfolio in Q3 2019, its #205 holding.
Neuburgh Advisers first reported a position in Elevance Health in Q4 2016 and has held it in 12 quarters since.
Neuburgh Advisers's Elevance Health position peaked at $18.3M in Q1 2018.
1,014 funds tracked by Wall St. Rank held Elevance Health as of Q3 2019.

Based on Neuburgh Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.